Precision Dosing In Cardiac Disease

Eurovet Animal Health has launched Cardisure®, a new look pimobendan that will help deliver more precise dosing in the treatment of cardiac disease. Dogs have the widest range in bodyweight of any species and it’s long been a problem accommodating the wide variation in dosage requirements that this leads to. Having to give too many tablets in a day or the need to struggle to split small tablets can be very discouraging to owners and may lead to poorer rates of compliance. Cardisure® is available in 1.25 mg, 2.5 mg, 5 mg tablets and a 10 mg tablet size. The tablets are easily divisible and palatable, making it easier all round for pet owners to administer the right dose of medication to their pet. The benefits of treating heart disease with pimobendan are well established and Cardisure® gives clinicians a few more client-friendly options when it comes to treating heart disease, as well as being available in smart and professional blister packs for easy dispensing.

More from

• Vetsure Named Business of the Year at 2025 SME National Business Awards
• Home of hope for Romania's dogs: The pioneering shelter doing things differently
• Pioneering new locum platform transforming veterinary landscape
• Key Stakeholders unite to advance helmet design for equine veterinary professionals
• Hallmarq hails transformational equine imaging technology